Onco-Innovations Ltd. is a Canadian biotech company, which engages in cancer research and treatment, specializing in oncology. The company is headquartered in Calgary, Alberta. The company went IPO on 2024-11-27. The firm holds an exclusive worldwide license to patented technology that targets solid tumors. The firm is engaged in developing and commercializing treatments for various types of cancer. Its solution focuses on targeting cancer cells, effectively eliminating them and preventing their regrowth. Its licensed technology focuses on Polynucleotide Kinase 3'-Phosphatase (PNKP) inhibitors. Its SynoGraph platform merges genomic, proteomic, and multimodal datasets to uncover deep insights into disease mechanisms, potentially enabling more personalized and effective treatment strategies.
Follow-Up Questions
Qui est le CEO de Onco-Innovations Ltd ?
Mr. Thomas Oshaughnessy est le Chief Executive Officer de Onco-Innovations Ltd, il a rejoint l'entreprise depuis 2024.
Quelle est la performance du prix de l'action ONNVF ?
Le prix actuel de ONNVF est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Onco-Innovations Ltd ?
Onco-Innovations Ltd appartient à l'industrie Biotechnology et le secteur est Health Care
Quelle est la capitalisation boursière de Onco-Innovations Ltd ?
La capitalisation boursière actuelle de Onco-Innovations Ltd est de $NaN
